Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
dc.contributor.author | Cavallari, Larisa H. | |
dc.contributor.author | Pratt, Victoria M. | |
dc.contributor.department | Medical and Molecular Genetics, School of Medicine | |
dc.date.accessioned | 2024-05-14T10:22:24Z | |
dc.date.available | 2024-05-14T10:22:24Z | |
dc.date.issued | 2022 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Cavallari LH, Pratt VM. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Clin Lab Med. 2022;42(4):533-546. doi:10.1016/j.cll.2022.09.009 | |
dc.identifier.uri | https://hdl.handle.net/1805/40706 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.cll.2022.09.009 | |
dc.relation.journal | Clinics in Laboratory Medicine | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Evidence | |
dc.subject | Genotype | |
dc.subject | Outcomes | |
dc.subject | Pharmacogenomics | |
dc.subject | Reimbursement | |
dc.title | Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing | |
dc.type | Article |